US FDA Releases Slew Of Guidances On A Fell Day For Complex Generics

 
• By Michael Cipriano

New and updated guidances are good news for ANDA sponsors, but timing – coming the day Sandoz announced a CRL for its Advair copy – underscores challenges that developers of complex generics face.  

Maze
Getting to ANDA approval can sometimes feel like getting through a labyrinth.

More from Generics

More from Biosimilars & Generics